熱門資訊> 正文
伯恩斯坦的阿吉隆健康状况因扭亏为盈
2026-09-16 00:16
- Bernstein upgraded agilon health (AGL) to outperform from market-perform, saying that that a turnaround is producing positive results.
- The firm boosted its price target to $125 from $86 (~35% upside based on Sept. 14 close).
- Recent evidence of the turnaround is that in Q2, adjusted EBITDA was $70M compared to a loss of $83M in the year-ago period, according to analyst Lance Wilkes.
- He sees adjusted EBITDA of $79M (company is projecting $85M) in 2026, $124M in 2027, and $160M in 2028.
- "AGL has prioritized profitability over growth by repricing contracts, reducing risk exposure, and controlling operating costs," Wilkes wrote. "The company has reduced MA membership from 527k to 426k and cut Part D exposure from 70% of its book in 2024 to 15%, contributing to significantly lower [medical loss ratio]."
More on agilon health
- agilon health: The Q2 Inflection Is Real
- agilon health, inc. (AGL) Q2 2026 Earnings Call Transcript
- agilon health: Q1 Inflection And A New CEO Set Up A Multi-Year Rerating
- Agilon raises 2026 outlook to $5.8B revenue and $85M adjusted EBITDA as risk adjustment estimate increases to 3%
- Seeking Alpha’s Quant Rating on agilon health
推薦文章
華盛早報 | 美聯儲鷹派加息「嚇壞」美股！沃什再度拒絕給出點陣圖；OpenAI提議設立AI安全報告機制；NEBIUS上調英偉達GPU租賃價
今夜加息概率升破92%！全球風暴即將來襲？覆盤近三輪加息周期，這次會走2015還是2022年劇本？
5%美債收益率風暴來襲！再融資炸彈倒計時開啟，誰會是第一個犧牲品？
美參議院加密市場結構法案程序性投票未獲通過 兩黨談判破裂致立法進程受阻
利率決議前夕黃金「搶跑」！美聯儲兩難困境正被看穿：加息是利空出盡，不加息金價衝5000？
扎克伯格稱更青睞依靠評估人員確保AI安全 而非放緩發展
攜程2026Q2淨利潤同比下降，受處罰費用影響，錄得淨虧損24億元！
加密貨幣法案折戟美國參議院！比特幣、以太幣跌至6月來最低
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
